Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy is a research paper published in Cancer Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: 1F32CA278313‐01
NCI NIH HHS
Grant: 1F32CA278313-01
NCI NIH HHS
Grant: R21 CA286257
NCI NIH HHS
Grant: F32 CA278313
National Institutes of Health
Grant: 5F32CA278313-02
Defining Protein Signature of Vascular Invasion in Hepatoblastoma
Macy Easom Cancer Research Foundation
FWCI
1.06
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals